Resumen de acción NEULANDLAB
Neuland Laboratories Limited fabrica y vende principios activos farmacéuticos (API) en India, Europa, Estados Unidos y a escala internacional.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Recompensas
Análisis de riesgos
No se han detectado riesgos en NEULANDLAB a partir de nuestros controles de riesgos.
Competidores de Neuland Laboratories Limited
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | ₹7,557.85 |
| 52 Week High | ₹7,790.00 |
| 52 Week Low | ₹2,031.05 |
| Beta | 1.02 |
| 1 Month Change | 16.89% |
| 3 Month Change | 22.98% |
| 1 Year Change | 267.80% |
| 3 Year Change | 182.00% |
| 5 Year Change | 1,026.19% |
| Change since IPO | 7,855.63% |
Noticias y actualizaciones recientes
There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19
We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Recent updates
There's Reason For Concern Over Neuland Laboratories Limited's (NSE:NEULANDLAB) Massive 25% Price Jump
Apr 19We Ran A Stock Scan For Earnings Growth And Neuland Laboratories (NSE:NEULANDLAB) Passed With Ease
Apr 15Subdued Growth No Barrier To Neuland Laboratories Limited (NSE:NEULANDLAB) With Shares Advancing 29%
Feb 17Revenue Beat: Neuland Laboratories Limited Exceeded Revenue Forecasts By 8.1% And Analysts Are Updating Their Estimates
Feb 12Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Jan 05The Neuland Laboratories Limited (NSE:NEULANDLAB) Analyst Just Boosted Their Forecasts By A Meaningful Amount
Nov 12Here's Why We Think Neuland Laboratories (NSE:NEULANDLAB) Might Deserve Your Attention Today
Oct 27Neuland Laboratories (NSE:NEULANDLAB) Seems To Use Debt Rather Sparingly
Aug 24Forecast: Analysts Think Neuland Laboratories Limited's (NSE:NEULANDLAB) Business Prospects Have Improved Drastically
Aug 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jul 05Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
Jun 21Neuland Laboratories (NSE:NEULANDLAB) Is Increasing Its Dividend To ₹10.00
May 14Should You Be Adding Neuland Laboratories (NSE:NEULANDLAB) To Your Watchlist Today?
May 12Here's Why Neuland Laboratories (NSE:NEULANDLAB) Can Manage Its Debt Responsibly
Aug 30I Built A List Of Growing Companies And Neuland Laboratories (NSE:NEULANDLAB) Made The Cut
Feb 23The Consensus EPS Estimates For Neuland Laboratories Limited (NSE:NEULANDLAB) Just Fell Dramatically
Feb 03Neuland Laboratories (NSE:NEULANDLAB) Has A Pretty Healthy Balance Sheet
Mar 15Can You Imagine How Elated Neuland Laboratories' (NSE:NEULANDLAB) Shareholders Feel About Its 391% Share Price Gain?
Feb 28Don't Ignore The Fact That This Insider Just Sold Some Shares In Neuland Laboratories Limited (NSE:NEULANDLAB)
Feb 12Neuland Laboratories Limited (NSE:NEULANDLAB) Just Reported And Analysts Have Been Lifting Their Price Targets
Feb 04Neuland Laboratories Limited's (NSE:NEULANDLAB) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Feb 03Read This Before Selling Neuland Laboratories Limited (NSE:NEULANDLAB) Shares
Jan 18
If You Like EPS Growth Then Check Out Neuland Laboratories (NSE:NEULANDLAB) Before It's Too Late
Jan 01Is Neuland Laboratories Limited (NSE:NEULANDLAB) Popular Amongst Insiders?
Dec 14Did Business Growth Power Neuland Laboratories' (NSE:NEULANDLAB) Share Price Gain of 117%?
Nov 26Rentabilidad de los accionistas
| NEULANDLAB | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | 8.4% | 0.8% | 0.5% |
| 1Y | 267.8% | 58.6% | 44.7% |
Rentabilidad vs. Industria: NEULANDLAB superó al sector Indian Pharmaceuticals , que obtuvo un rendimiento del 56.7% el año pasado.
Rentabilidad vs. Mercado: NEULANDLAB superó al mercado Indian, que obtuvo un rendimiento del 46.4% el año pasado.
Volatilidad de los precios
| NEULANDLAB volatility | |
|---|---|
| NEULANDLAB Average Weekly Movement | 7.4% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in IN Market | 10.0% |
| 10% least volatile stocks in IN Market | 4.2% |
Precio estable de las acciones: El precio de las acciones de NEULANDLAB ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de NEULANDLAB (8%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1984 | 1,554 | Davuluri Rao | www.neulandlabs.com |
Neuland Laboratories Limited fabrica y vende principios activos farmacéuticos (API) en India, Europa, Estados Unidos y a escala internacional. Los API de la empresa se utilizan en diversas áreas terapéuticas, como antiasmáticos, cardiovasculares, antifúngicos, anticonvulsivos, sistema nervioso central, fluoroquinolonas, antipsicóticos, antibacterianos y antiparkinsonianos. También ofrece soluciones de fabricación a medida, así como servicios de síntesis de péptidos.
Resumen de fundamentos de Neuland Laboratories Limited
| Estadísticas fundamentales de NEULANDLAB | |
|---|---|
| Capitalización bursátil | ₹96.75b |
| Beneficios(TTM) | ₹3.17b |
| Ingresos (TTM) | ₹15.81b |
30.5x
Ratio precio-beneficio (PE)6.1x
Ratio precio-ventas (PS)¿Está NEULANDLAB sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de NEULANDLAB | |
|---|---|
| Ingresos | ₹15.81b |
| Coste de los ingresos | ₹7.62b |
| Beneficio bruto | ₹8.18b |
| Otros gastos | ₹5.01b |
| Beneficios | ₹3.17b |
Últimos beneficios comunicados
Dec 31, 2023
Próxima fecha de beneficios
May 10, 2024
| Beneficios por acción (BPA) | 247.13 |
| Margen bruto | 51.77% |
| Margen de beneficio neto | 20.06% |
| Ratio deuda/patrimonio | 8.9% |
¿Cómo se ha desempeñado NEULANDLAB a largo plazo?
Ver rendimiento histórico y comparativa